152 AERATE-lung: management and prophylaxis of EGFR inhibitor skin adverse events in NSCLC: variations between dermatologists and oncology teams in the UK
Fields of Study & Subjects
Chemotherapy-related skin toxicity
Lung Cancer Treatments and Mutations
HER2/EGFR in Cancer Research
Publication details
- Journal / source
- Lung Cancer
- Volume
- 212
- Pages
- 109100–109100
- Publication date
- 1 February 2026
- Language
- EN